SCHEMBL13382015

SCHEMBL13382015

Cc1ccc(COc2nc(SC(=O)N(C)C)ns2)c(C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.38
KDM4A O75164 1/20 0.36
KDM5A P29375 1/20 0.36
KDM2B Q8NHM5 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
KDM5B Q9UGL1 1/20 0.36
KMT2A Q03164 2/20 0.31
ALDH1A1 P00352 1/20 0.31
PSEN1 P49768 1/20 0.31
PSEN2 P49810 1/20 0.31
APH1B Q8WW43 1/20 0.31
NCSTN Q92542 1/20 0.31
APH1A Q96BI3 1/20 0.31
PSENEN Q9NZ42 1/20 0.31
P2RX7 Q99572 1/20 0.31
MEN1 O00255 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13381979 0.84 ALDH1A1 (0.38) MAPTKMT2AALDH1A1MEN1CYP1A2
SCHEMBL13381975 0.82 MAOB (0.42) MAPTALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL13381993 0.81 ADORA3 (0.41) MAPTKMT2AALDH1A1MEN1CYP1A2
SCHEMBL13382018 0.81 NPC1 (0.32) MAPTKMT2AALDH1A1MEN1
SCHEMBL13382005 0.79 ALKBH1 (0.36) KMT2AMEN1MMP1L3MBTL1
SCHEMBL13381999 0.79 MAOB (0.39) MAPTKMT2AALDH1A1MEN1CYP1A2
SCHEMBL13398860 0.79 MAPK14 (0.32) KDM5AKDM4CKDM5B
SCHEMBL13381968 0.79 MAOB (0.41) MAPTKMT2AALDH1A1MEN1
SCHEMBL13381967 0.79 MAOB (0.41) KMT2AALDH1A1MEN1L3MBTL1
SCHEMBL13398887 0.79 RAB9A (0.31) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100081693-A1 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-01 US disclosed
US-20100081693-A1 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-01 US disclosed
WO-2008032858-A2 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081693-A1 THIADIAZOLE COMPOUND AND USE THEREOF NR2C2, NR4A3, NR0B2 MAPT 4375/4885KDM4A 3856/4885KDM5A 4181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.